A Journey Into Participation Patterns Among Metastatic Prostate Cancer Patients

Engagement Trends in Clinical Trials for Metastatic Prostate Cancer - A Journey Into Participation Patterns Among Individuals Affected by the Condition

Taking part in clinical trials usually favors a particular demographic group. But there is limited research available to explain what trial attributes affect the completion of these specific demographic groups.

This research will admit a wide range of data on the clinical study experience of metastatic prostate cancer patients to determine which factors prevail in limiting a patient's ability to join or finish a trial.

It will also try to analyze data from the perspective of different demographic groups to check for recurring trends which might yield insights for the sake of future patients with metastatic prostate cancer.

Inclusion Criteria:

• Patient is at least 18 years of age
• Diagnosis of metastatic prostate cancer
• Ability to understand and the willingness to sign a written informed consent document

Exclusion Criteria:

• Enrolled in another research study
• Patients with psychiatric illness/social situations that would limit compliance with study requirements
• Inability to provide written informed consent